Making sense of Sequoia Capital's big China breakup
Sequoia is spinning off its China and India units into independent firms.
Stay updated with breaking news from Colorcon Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sequoia is spinning off its China and India units into independent firms.
/PRNewswire/ -- Mend™, a life sciences and digital health company operating at the intersection of nutrapharma, food as medicine, and behavioral health,...
Novome Biotechnologies has raised $43.5m in a Series B financing round to advance its therapeutically engineered microbes’ pipeline.
Novome Biotechnologies — a biotech that CEO Blake Wise says is only company to pursue engineered cell therapy with microbes for the treatment of chronic diseases — raised $43.5 million in Series B funds. The biotech will use the money to advance clinical testing for its lead drug candidate, which seeks to decrease patients' urinary oxalate, as well as advance its pipeline of preclinical genetically engineered microbes.
/PRNewswire/ -- Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Apprentice.io, a leading provider of Intelligent Manufacturing...